Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients

MicroRNAs fine-tune the regulation of Th1/Th17 lymphocyte subsets in multiple sclerosis. We investigated the expression of miRNAs (previously associated with mycobacterial and viral infections) in MS patients and healthy donors (HD) following 6 months natalizumab therapy. In addition, Th1/Th17 cytok...

Descripción completa

Detalles Bibliográficos
Autores principales: Mameli, Giuseppe, Arru, Giannina, Caggiu, Elisa, Niegowska, Magdalena, Leoni, Stefania, Madeddu, Giordano, Babudieri, Sergio, Sechi, Gian Pietro, Sechi, Leonardo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911163/
https://www.ncbi.nlm.nih.gov/pubmed/27310932
http://dx.doi.org/10.1371/journal.pone.0157153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911163/
https://www.ncbi.nlm.nih.gov/pubmed/27310932
http://dx.doi.org/10.1371/journal.pone.0157153

Ejemplares similares